Jakob Brix Christensen

Vorstandsvorsitzender bei Unibio AS

Health Technology

Process Industries

Profil

Jakob Brix Christensen is currently the Co-Chief Executive Officer at Unibio.
AS since 2021.
Prior to this, he worked as the Director-Investor Relations at Origio A from 2007 to 2012, Senior Manager-Business Finance at Novozymes A from 2012 to 2013, Partner-Business Finance at Albumedix A from 2013 to 2015, and Chief Financial Officer at Bioporto A from 2016 to 2018.

Aktive Positionen von Jakob Brix Christensen

Unternehmen	Position	Beginn
Unibio AS Unibio AS BiotechnologyHealth Technology Unibio AS is a Danish biotechnology company that operates in an undisclosed location. The private company was founded in 2001, and its CEOs are Jakob Brix Christensen, Sten Bay Jørgensen, and David Richard Henstrom.	Vorstandsvorsitzender	27.06.2021

Alle aktiven Positionen von Jakob Brix Christensen

Ehemalige bekannte Positionen von Jakob Brix Christensen

Unternehmen	Position	Ende
BIOPORTO A/S	Finanzdirektor/CFO	01.06.2018
Albumedix A/S Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark.	Corporate Officer/Principal	01.12.2015
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.	Corporate Officer/Principal	01.04.2013
Origio A/S Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark.	Public Communications Contact	01.04.2012

Sehen Sie sich die Erfahrung von Jakob Brix Christensen im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jakob Brix Christensen im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
BIOPORTO A/S	Health Technology

Private Unternehmen	4
Origio A/S Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark.	Health Technology
Albumedix A/S Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark.	Health Technology
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.	Process Industries
Unibio AS Unibio AS BiotechnologyHealth Technology Unibio AS is a Danish biotechnology company that operates in an undisclosed location. The private company was founded in 2001, and its CEOs are Jakob Brix Christensen, Sten Bay Jørgensen, and David Richard Henstrom.	Health Technology

Sehen Sie sich die Unternehmensverbindungen an